Loading...
Loading...
CVRX| Name | Value |
|---|---|
| Revenues | 15.3M |
| Cost of Revenue | 2.3M |
| Gross Profit | 13.0M |
| Operating Expense | 23.3M |
| Operating I/L | -10.3M |
| Other Income/Expense | -0.4M |
| Interest Income | -1.0M |
| Pretax | -10.7M |
| Income Tax Expense | -0.1M |
| Net Income/Loss | -10.7M |
CVRx, Inc. is a medical device company specializing in neuromodulation solutions for patients with cardiovascular diseases. Its flagship product, Barostim, is a neuromodulation device designed to alleviate symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company generates revenue by selling its products through a combination of direct sales force, sales agents, and independent distributors in the United States, Germany, rest of Europe, and internationally.
